Johnson & Johnson pays $5.5B over baby powder cancer claims

Johnson & Johnson has settled lawsuits related to claims that baby powder and talc-based products cause ovarian cancer, for a total amount of $5.5 billion. The settlement covered approximately 69,000 cases, representing 99.75% of all talc-related lawsuits, and was approved by both federal and state courts. Johnson & Johnson’s vice president explained that the company was confident that the claims were unfounded, but decided to resolve the disputes definitively. The company continues to focus on developing life-saving medicines and devices. This comes after the company achieved a significant legal victory when a judge questioned the plaintiffs' ability to prove a link between talc and ovarian cancer. In 2020, Johnson & Johnson stopped selling talc-based baby powder in the United States and replaced it with corn starch-based products.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل